CRESEMBA caps 100 mg 14 pce
7680661720016
CH-66172
J02AC05
08.06.0.
Reimbursement limitations:
CRESE.Kps.IA
Aspergillose invasive (AI)
Cresemba est remboursé pour le traitement de l’AI chez les adultes et …
1 / 2
google
Details
- Product number
- 6617201
- CPT
- -
- Packaging group
- 14
- Unit
- Kapsel(n)
- Composition
- isavuconazonium 100 mg ut isavuconazonii sulfas, magnesii citras, cellulosum microcristallinum, talcum, silica colloidalis anhydrica, acidum stearicum, Kapselhülle: hypromellosum, E 172 (rubrum), E 171, gellani gummi, kalii acetas, dinatrii edetas, natrii laurilsulfas, Drucktinte: lacca, propylenglycolum, ammoniae solutio concentrata, E 172 (nigrum), kalii hydroxidum, pro capsula corresp. natrium ca. 0.2 mg.
Articles (1)
Cresemba 100 mg, Hartkapseln
Kapseln
14
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HIMDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HBESI |
Reimbursement information
Public price
CHF 781.60
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/03/2018
Authorization holder
Basilea Pharmaceutica
4123 Allschwil
Authorization information
- Swissmedic authorization number
- 66172
- Drug name
- Cresemba, Hartkapseln
- Galenic form
- KAHA
- ATC Code
- J02AC05
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 20/10/2017
- Authorization expiration date
- 31/12/9999
- IT number
- 08.06.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- CRESEMBA caps 100 mg 14 pce
- Description (DE)
- CRESEMBA Kaps 100 mg 14 Stk
- Market launch
- 20/10/2017
- Narcotic (BTM)
- No